IOL Chemicals & Pharmaceuticals Stock Screener | Share Price & Fundamental Analysis
IOLCP
Pharmaceuticals
Screen IOL Chemicals & Pharmaceuticals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹81.40
▼
-1.60 (-1.93%)
Share Price BSE
₹81.46
▼
-1.49 (-1.80%)
Market Cap
₹2,389.30 Cr.
P/E Ratio (TTM)
20.62
P/B Ratio
1.37
EPS (TTM)
₹3.44
Dividend Yield
0.98%
Debt to Equity
0.05
52W High
₹119.30
52W Low
₹59.35
Operating Margin
12.00%
Profit Margin
5.83%
Revenue (TTM)
₹532.00
EBITDA
₹67.00
Net Income
₹31.00
Total Assets
₹2,382.00
Total Equity
₹1,688.00
IOL Chemicals & Pharmaceuticals Share Price History - Stock Screener Chart
Screen IOLCP historical share price movements with interactive charts. Analyze price trends and patterns.
IOL Chemicals & Pharmaceuticals Company Profile - Fundamental Screener
Screen IOL Chemicals & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for IOLCP shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE485C01029
IOL Chemicals & Pharmaceuticals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen IOLCP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 2,382 | 2,244 | 2,022 | 1,962 |
| Current Assets | 1,151 | 1,120 | 920 | 1,081 |
| Fixed Assets | 1,171 | 933 | 752 | 561 |
| Liabilities | ||||
| Total Liabilities | 2,382 | 2,244 | 2,022 | 1,962 |
| Current Liabilities | 85 | 73 | 58 | 57 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 1,688 | 1,612 | 1,508 | 1,392 |
| Share Capital | 59 | 59 | 59 | 59 |
| Reserves & Surplus | 1,629 | 1,553 | 1,449 | 1,334 |
IOL Chemicals & Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Intrinsic ValueScreen IOLCP income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 532 | 559 | 574 | 511 | 510 | 532 | 527 | 596 | 570 | 552 | 529 | 579 | 570 | 547 | 530 |
| Expenses | 465 | 490 | 511 | 454 | 451 | 484 | 476 | 492 | 491 | 481 | 476 | 527 | 509 | 510 | 481 |
| EBITDA | 67 | 70 | 64 | 57 | 59 | 48 | 51 | 104 | 80 | 71 | 53 | 52 | 61 | 37 | 49 |
| Operating Profit % | 12.00% | 11.00% | 10.00% | 10.00% | 10.00% | 8.00% | 9.00% | 16.00% | 13.00% | 12.00% | 9.00% | 8.00% | 10.00% | 6.00% | 8.00% |
| Depreciation | 19 | 20 | 20 | 16 | 17 | 18 | 19 | 12 | 14 | 16 | 16 | 11 | 11 | 11 | 12 |
| Interest | 4 | 4 | 4 | 3 | 2 | 4 | 5 | 5 | 4 | 4 | 4 | 2 | 3 | 4 | 5 |
| Profit Before Tax | 45 | 46 | 41 | 37 | 40 | 26 | 28 | 87 | 61 | 51 | 32 | 39 | 47 | 22 | 33 |
| Tax | 13 | 12 | 11 | 10 | 10 | 7 | 7 | 22 | 15 | 13 | 9 | 9 | 12 | 6 | 9 |
| Net Profit | 31 | 34 | 30 | 28 | 30 | 19 | 21 | 65 | 46 | 38 | 23 | 30 | 35 | 16 | 24 |
| EPS | 1.07 | 1.16 | 1.02 | 4.71 | 5.11 | 3.26 | 3.50 | 11.03 | 7.81 | 6.45 | 3.93 | 5.07 | 5.91 | 2.71 | 4.05 |
IOL Chemicals & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen IOLCP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 179 | 290 | 122 | 93 |
| Investing Activities | -154 | -191 | -120 | -121 |
| Financing Activities | 46 | -93 | -4 | -2 |
| Net Cash Flow | 71 | 6 | -2 | -29 |
Screen IOLCP shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.62% | 52.62% | 52.62% | 48.19% | 48.19% | 48.19% | 52.62% | 48.19% |
| FII Holding | 1.47% | 2.59% | 2.25% | 1.41% | 1.39% | 1.63% | 1.49% | 0.00% |
| DII Holding | 0.07% | 0.02% | 0.04% | 0.30% | 0.10% | 0.08% | 0.08% | 0.02% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 31.43% | 30.22% | 29.97% | 30.98% | 31.48% | 31.31% | 31.23% | 30.49% |
| Other Holding | 14.40% | 14.54% | 15.12% | 19.12% | 18.84% | 18.79% | 14.58% | 21.30% |
| Shareholder Count | 130,002 | 125,040 | 136,129 | 130,003 | 128,689 | 125,979 | 126,701 | 140,177 |
IOL Chemicals & Pharmaceuticals Dividend Screener - Share Yield Analysis
Screen IOLCP dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.80 | 0.98% |
| 2024-March | ₹5.00 | 8.18% |
| 2023-March | ₹4.00 | 5.53% |
| 2022-March | ₹4.00 | 7.07% |
| 2021-March | ₹6.00 | 8.48% |
| 2020-March | ₹3.00 | 2.72% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
IOL Chemicals & Pharmaceuticals Index Membership - Market Screener Classification
Screen IOLCP by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
IOL Chemicals & Pharmaceuticals Market Events Screener - Corporate Actions
Screen IOLCP market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 2.00 /share | -22.67% | ||
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -5.32% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | 27.43% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 0.92% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 18.62% |
| 2025-03-11 | 2024-12-27 | Split | 2:10 | 0.00% |
| 2025-02-18 | 2025-02-18 | Dividend | ₹ 4.00 /share | -7.33% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | 1.31% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.34% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 24.87% |
| 2024-02-16 | 2024-02-16 | Dividend | ₹ 5.00 /share | -6.06% |
| 2023-02-17 | 2023-02-17 | Dividend | ₹ 4.00 /share | 1.13% |
| 2022-02-15 | 2022-02-16 | Dividend | ₹ 4.00 /share | -15.58% |
IOL Chemicals & Pharmaceuticals Competitors Screener - Peer Comparison
Screen IOLCP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 422,331 | 40.28 | 54,729 | 9.71% | 10,980 | 53.13 |
| Divis Laboratories | 176,338 | 70.98 | 9,712 | 18.67% | 2,191 | 63.15 |
| Torrent Pharmaceuticals | 133,239 | 62.26 | 11,539 | 6.99% | 1,911 | 71.28 |
| Cipla | 123,654 | 22.75 | 28,410 | 7.12% | 5,291 | 57.84 |
| Dr Reddys Laboratories | 104,846 | 18.27 | 33,741 | 16.73% | 5,725 | 46.16 |
| Lupin | 98,198 | 22.61 | 22,910 | 13.74% | 3,306 | 63.46 |
| Zydus Life Science | 93,685 | 18.63 | 23,511 | 18.55% | 4,615 | 54.52 |
| Mankind Pharma | 92,501 | 52.17 | 12,744 | 20.90% | 2,007 | 56.13 |
| Aurobindo Pharma | 71,514 | 20.91 | 32,346 | 9.43% | 3,484 | 60.21 |
| Alkem Laboratories | 67,620 | 28.04 | 13,458 | 3.70% | 2,216 | 55.49 |
IOL Chemicals & Pharmaceuticals Company Announcements - News Screener
Screen IOLCP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Closure of Trading Window | View |
| 2025-12-05 | EDQM Issued CEP Certificate For MINOXIDIL | View |
| 2025-11-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-11 | Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-11 | Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-04 | Board Meeting Intimation for Notice Of Board Meeting | View |
| 2025-10-27 | EDQM Issued CEP Certificate For Sitagliptin Phosphate Monohydrate | View |
| 2025-10-24 | Intimation Of Incorporation Of Wholly Owned Subsidiary | View |
| 2025-10-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-15 | EDQM Issued CEP Certificate For Pantoprazole Sodium Sesquihydrate Process-III | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Intimation On Receipt Of Request For Re-Lodgement Of Transfer Requests Of Physical Shares | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |